NCT00433849 - Clinical Study of R744 to Peritoneal Dialysis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions

Peritoneal Dialysis Patients

Interventions

DRUG

R744

100μg(i.v./p.o.)/4weeks for 8 weeks, then 25\~400μg(i.v./p.o.)/4weeks for 40 weeks

DRUG

R744

150μg(i.v./p.o.)/4weeks for 8 weeks, then 25\~400μg(i.v./p.o.)/4weeks for 40 weeks

Trial Locations (6)

Chugoku/Shikoku region, Chugoku/Shikoku

Chubu region, Chūbu

Hokkaido/Tohoku region, Hokkaido/Tohoku

Kanto/Koshinetsu region, Kanto/Koshinetsu

Kinki/Hokuriku region, Kinki/Hokuriku

Kyusyu region, Kyusyu